Injectable Drugs Delivery

Injectable Drugs Delivery

Injectable Drugs Delivery market worldwide is projected to grow by US$423.4 Billion, driven by a compounded growth of 11%. Device, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$172.8 Billion by the year 2025, Device will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$20.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$19.4 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Device will reach a market size of US$17 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.7% over the next couple of years and add approximately US$73.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Baxter International, Inc.; Becton, Dickinson and Company; Elcam Medical; Eli Lilly and Company; Gerresheimer AG; INJEX Pharma GmbH; Novartis International AG; Novo Nordisk A/S; SCHOTT AG; Terumo Corporation; Teva Pharmaceuticals USA, Inc.; West Pharmaceutical Services, Inc.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Injectable Drugs Delivery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Injectable Drugs Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Injectable Drugs Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Injectable Drugs Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Device (Segment) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Device (Segment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Device (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Formulation (Segment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Formulation (Segment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Formulation (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Hospitals & Clinics (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 11: Hospitals & Clinics (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
TABLE 12: Hospitals & Clinics (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Home Care (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
TABLE 14: Home Care (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 15: Home Care (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Research Laboratories (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 17: Research Laboratories (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 18: Research Laboratories (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Other End-Uses (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
TABLE 20: Other End-Uses (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
TABLE 21: Other End-Uses (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Injectable Drugs Delivery Market Share (in %) by Company: 2019 & 2025
TABLE 22: United States Injectable Drugs Delivery Market Estimates and Projections in US$ Million by Segment: 2018 to 2025
TABLE 23: Injectable Drugs Delivery Market in the United States by Segment: A Historic Review in US$ Million for 2009-2017
TABLE 24: United States Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
TABLE 25: United States Injectable Drugs Delivery Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 26: Injectable Drugs Delivery Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
TABLE 27: Injectable Drugs Delivery Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 28: Canadian Injectable Drugs Delivery Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025
TABLE 29: Canadian Injectable Drugs Delivery Historic Market Review by Segment in US$ Million: 2009-2017
TABLE 30: Injectable Drugs Delivery Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
TABLE 31: Canadian Injectable Drugs Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 32: Injectable Drugs Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 33: Canadian Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 34: Japanese Market for Injectable Drugs Delivery: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025
TABLE 35: Injectable Drugs Delivery Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017
TABLE 36: Japanese Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
TABLE 37: Japanese Demand Estimates and Forecasts for Injectable Drugs Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 38: Japanese Injectable Drugs Delivery Market in US$ Million by End-Use: 2009-2017
TABLE 39: Injectable Drugs Delivery Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 40: Chinese Injectable Drugs Delivery Market Growth Prospects in US$ Million by Segment for the Period 2018-2025
TABLE 41: Injectable Drugs Delivery Historic Market Analysis in China in US$ Million by Segment: 2009-2017
TABLE 42: Chinese Injectable Drugs Delivery Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 43: Chinese Demand for Injectable Drugs Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 44: Injectable Drugs Delivery Market Review in China in US$ Million by End-Use: 2009-2017
TABLE 45: Chinese Injectable Drugs Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Injectable Drugs Delivery Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 46: European Injectable Drugs Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 47: Injectable Drugs Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 48: European Injectable Drugs Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 49: European Injectable Drugs Delivery Market Estimates and Forecasts in US$ Million by Segment: 2018-2025
TABLE 50: Injectable Drugs Delivery Market in Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017
TABLE 51: European Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
TABLE 52: European Injectable Drugs Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 53: Injectable Drugs Delivery Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 54: European Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
TABLE 55: Injectable Drugs Delivery Market in France by Segment: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 56: French Injectable Drugs Delivery Historic Market Scenario in US$ Million by Segment: 2009-2017
TABLE 57: French Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
TABLE 58: Injectable Drugs Delivery Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
TABLE 59: French Injectable Drugs Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 60: French Injectable Drugs Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
GERMANY
TABLE 61: Injectable Drugs Delivery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2018-2025
TABLE 62: German Injectable Drugs Delivery Historic Market Analysis in US$ Million by Segment: 2009-2017
TABLE 63: German Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
TABLE 64: Injectable Drugs Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 65: German Injectable Drugs Delivery Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 66: Injectable Drugs Delivery Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
TABLE 67: Italian Injectable Drugs Delivery Market Growth Prospects in US$ Million by Segment for the Period 2018-2025
TABLE 68: Injectable Drugs Delivery Historic Market Analysis in Italy in US$ Million by Segment: 2009-2017
TABLE 69: Italian Injectable Drugs Delivery Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 70: Italian Demand for Injectable Drugs Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 71: Injectable Drugs Delivery Market Review in Italy in US$ Million by End-Use: 2009-2017
TABLE 72: Italian Injectable Drugs Delivery Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 73: United Kingdom Market for Injectable Drugs Delivery: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2018-2025
TABLE 74: Injectable Drugs Delivery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2009-2017
TABLE 75: United Kingdom Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
TABLE 76: United Kingdom Demand Estimates and Forecasts for Injectable Drugs Delivery in US$ Million by End-Use: 2018 to 2025
TABLE 77: United Kingdom Injectable Drugs Delivery Market in US$ Million by End-Use: 2009-2017
TABLE 78: Injectable Drugs Delivery Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 79: Rest of Europe Injectable Drugs Delivery Market Estimates and Forecasts in US$ Million by Segment: 2018-2025
TABLE 80: Injectable Drugs Delivery Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2009-2017
TABLE 81: Rest of Europe Injectable Drugs Delivery Market Share Breakdown by Segment: 2009 VS 2019 VS 2025
TABLE 82: Rest of Europe Injectable Drugs Delivery Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 83: Injectable Drugs Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 84: Rest of Europe Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 85: Injectable Drugs Delivery Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 86: Asia-Pacific Injectable Drugs Delivery Historic Market Scenario in US$ Million by Segment: 2009-2017
TABLE 87: Asia-Pacific Injectable Drugs Delivery Market Share Analysis by Segment: 2009 VS 2019 VS 2025
TABLE 88: Injectable Drugs Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
TABLE 89: Asia-Pacific Injectable Drugs Delivery Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 90: Asia-Pacific Injectable Drugs Delivery Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
REST OF WORLD
TABLE 91: Rest of World Injectable Drugs Delivery Market Estimates and Forecasts in US$ Million by Segment: 2018 to 2025
TABLE 92: Rest of World Injectable Drugs Delivery Historic Market Review by Segment in US$ Million: 2009-2017
TABLE 93: Injectable Drugs Delivery Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025
TABLE 94: Rest of World Injectable Drugs Delivery Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 95: Injectable Drugs Delivery Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 96: Rest of World Injectable Drugs Delivery Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
IV. COMPETITION
BAXTER INTERNATIONAL
ELCAM MEDICAL
ELI LILLY AND COMPANY
GERRESHEIMER AG
INJEX PHARMA GMBH
NOVARTIS INTERNATIONAL AG
NOVO NORDISK A/S
SCHOTT AG
TERUMO CORPORATION
TEVA PHARMACEUTICALS USA
WEST PHARMACEUTICAL SERVICES
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook